Prostate cancer awareness and education


Prostate cancer is the most common non-skin cancer diagnosed among men who live in the United States. The American Cancer Society estimates that there will be over 161,000 new cases of prostate cancer in the U.S. in 2017, about 20% of all U.S. cancer diagnoses among males.

While highly-treatable, with 99% relative 5-year survivability rates when blended for all stages, prostate cancer will cause nearly 27,000 deaths in 2017, making it the third-leading cause of cancer deaths among men in the United States, trailing only lung cancer and colon cancer.

Learn More

Academy Bus: Official Sponsor of the Summer Road Trip 2017

Academy Bus: Official Sponsor of the Summer Road Trip 2017

We’re excited to share that for the second year in a row, Academy Bus is our official sponsor for the Summer Road Trip. Fans for the Cure has again partnered with the Hoboken NJ-based bus company to bring prostate cancer awareness and education to Minor League Baseball stadiums throughout the country.

Together with Academy Bus, we’re bringing PSA screenings and prostate cancer educational information to men in their own communities. We’ll be in your local community soon, so join us for good fun and important educational information about prostate cancer.

Check Out the Schedule

Summer Road Trip 2017

There are no upcoming events at this time.

Shop with AmazonSmile + Support Our Work

Shop with AmazonSmile

With AmazonSmile, your online shopping can help support our work to raise awareness about prostate cancer and help keep men healthier.

Go shop on AmazonSmile

We’re Working Every Day to Raise Awareness About Prostate Cancer

At Fans for the Cure we are committed to the reversing national trends by increasing the number of men who undergo PSA screenings for prostate cancer and reducing the growing number of men who are being diagnosed with later-stage variants of the disease. Working closely with our Medical Advisory Board, we also seek to serve as an information repository for men and their families in leading them to the most effective and least invasive treatment options.